In lung cancer, KDDs were detected at a ratio of 0.1% (56 out of 43,795), including EGFR KDD (48), MET KDD (4), BRAF KDD (2), FGFR1 KDD(1), and FLT3 KDD (1). Here, BRAF is linked to lung carcinoma.